Evidence map›Paper›PMID 26062895›Full record

ArticleScientific reports2015

The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death.

Florian J Bock, Maria C Tanzer, Manuel D Haschka, Gerhard Krumschnabel, Bénédicte Sohm, Katrin Goetsch, Reinhard Kofler, Andreas Villunger

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Anti-carcinogenic effects and mechanisms of actions ofAmerican journal of cancer research · 2024
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 4 countries.

Florian J BockDivision of Developmental Immunology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Maria C TanzerDivision of Developmental Immunology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Manuel D HaschkaDivision of Developmental Immunology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Gerhard KrumschnabelDivision of Developmental Immunology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Bénédicte SohmDivision of Developmental Immunology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Katrin GoetschDivision of Molecular Pathophysiology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Reinhard KoflerDivision of Molecular Pathophysiology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Andreas VillungerDivision of Developmental Immunology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Innsbruck Medical University · ATWalter and Eliza Hall Institute of Medical Research · AU

Funding

Austrian Science Fund FWF P 26856
6 · The paper itself

Abstract

The tumour suppressor p53 is an important mediator of cell cycle arrest and apoptosis in response to DNA damage, acting mainly by transcriptional regulation of specific target genes. The exact details how p53 modulates this decision on a molecular basis is still incompletely understood. One mechanism of regulation is acetylation of p53 on lysine K120 by the histone-acetyltransferase Tip60, resulting in preferential transcription of proapoptotic target genes. PDCD5, a protein with reported pro-apoptotic function, has recently been identified as regulator of Tip60-dependent p53-acetylation. In an effort to clarify the role of PDCD5 upon DNA damage, we generated cell lines in which PDCD5 expression was conditionally ablated by shRNAs and investigated their response to genotoxic stress. Surprisingly, we failed to note a rate-limiting role of PDCD5 in the DNA damage response. PDCD5 was dispensable for DNA damage induced apoptosis and cell cycle arrest and we observed no significant changes in p53 target gene transcription. While we were able to confirm interaction of PDCD5 with p53, we failed to do so for Tip60. Altogether, our results suggest a role of PDCD5 in the regulation of p53 function but unrelated to cell cycle arrest or apoptosis, at least in the cell types investigated.

Indexed as

AcetylationAnimalsApoptosisApoptosis Regulatory ProteinsCell Cycle CheckpointsCell Line, TumorDNA DamageDNA RepairGene Expression RegulationHCT116 CellsHistone AcetyltransferasesHumansLysine Acetyltransferase 5MiceNeoplasm ProteinsRNA InterferenceApoptosis Regulatory ProteinsHistone AcetyltransferasesKAT5 protein, humanLysine Acetyltransferase 5Neoplasm ProteinsPDCD5 protein, humanRNA, Small InterferingTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID26062895
PMCPMC4462756
OpenAlexW2175387819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.